Oct 16, 2025 7:00 am EDT First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
Sep 30, 2025 7:00 am EDT CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler
Aug 25, 2025 7:00 am EDT CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
Aug 20, 2025 7:00 am EDT COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Aug 5, 2025 7:00 am EDT COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS
Jul 14, 2025 7:00 am EDT CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations
Jun 4, 2025 7:00 am EDT COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS
